John P Kummer Ltd Announce an Expanded Range of Epoxy Technology Inc. Adhesives in Their Comprehensive MED Line Biocompatible Epoxies

Epoxy Technology Inc, a leading manufacturer of high-performance speciality adhesives for over 52 years, is pleased to announce an expanded range of ISO-10993 medically approved adhesives now totalling 23 products.

To date, 14 epoxies have undergone ISO-10993-5 Cytotoxicity testing, an excellent screening test for biocompatibility, and 9 additional products have undergone even more screening, passing all ISO-10993 -4,5,6,10,11 testing. Included in testing for EPO-TEK MED-301 was an extended implantation test, from the normal 2 weeks to 12 weeks, which it passed. This specific optically clear epoxy adhesive is one of the most popular and well-proven materials often used for moulding header systems on many types of devices including pacemakers, ICDs and neurostimulators.

Joan Bramer, Global Sales and Marketing Director of Epoxy Technology Inc. said ‘We are committed to testing all of our MED adhesives to the industry’s most comprehensive ISO-10993 biocompatibility standards and will continue to perform this level of testing, adding more adhesives to this important line of products in the coming year. We recognise the importance of this testing, as well as the critical quality assurance requirements needed in the medical device design and manufacturing community and are proud to be a trusted and leading supplier to them’.

All Epoxy Technology MED datasheets are available online and contain information on specific applications, testing methodology, extensive product data, as well as sterilisation compatibility.

John P Kummer Ltd, a specialist distributor of instruments used in the manufacturing of semiconductors, are the official distributor in the UK/Ireland for the complete range of EPO-TEK adhesives.

Rex Sandbach, Director of John P Kummer Ltd, said ‘We are proud to distribute EPO-TEK Epoxy adhesives, knowing that they have passed such important biocompatibility standards and quality assurance tests. It is great news that all of the Epoxy adhesives that we distribute from the line of biocompatible adhesives have been tested to the most stringent ISO-10993 testing method.’

John P Kummer Ltd were recently appointed as exclusive European distributors for the TAEHA and NSW Automation manufactured dispensers in 2018 to add to their existing Precifluid® line.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    John P. Kummer Ltd. (2019, March 17). John P Kummer Ltd Announce an Expanded Range of Epoxy Technology Inc. Adhesives in Their Comprehensive MED Line Biocompatible Epoxies. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=50708.

  • MLA

    John P. Kummer Ltd. "John P Kummer Ltd Announce an Expanded Range of Epoxy Technology Inc. Adhesives in Their Comprehensive MED Line Biocompatible Epoxies". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=50708>.

  • Chicago

    John P. Kummer Ltd. "John P Kummer Ltd Announce an Expanded Range of Epoxy Technology Inc. Adhesives in Their Comprehensive MED Line Biocompatible Epoxies". AZoM. https://www.azom.com/news.aspx?newsID=50708. (accessed November 24, 2024).

  • Harvard

    John P. Kummer Ltd. 2019. John P Kummer Ltd Announce an Expanded Range of Epoxy Technology Inc. Adhesives in Their Comprehensive MED Line Biocompatible Epoxies. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=50708.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.